Diagnostics and Therapeutics for Inborn Diseases
Join Our Mission
Analyze complex genetic information for improved patient outcomes
Our Services

Inborn Disease - A Global Challenge

350M+
Rare Diseases affect 350 million people worldwide, more than 175 million are children
80%
Origin of 80% rare diseases is genetic. 30% will not live to see their 5th birthday.
1 in 20
Rare Diseases affect 1 in 20 people in India. India is becoming a hub of rare diseases.
Previous slide
Next slide

350M+

Rare Diseases affect 350 million people worldwide, more than 175 million are children

80%

Origin of 80% rare diseases is genetic. 30% will not live to see their 5th birthday.

1 in 20

Rare Diseases affect 1 in 20 people in India. India is becoming a hub of rare diseases.

Diagnostics for Rare Diseases

It takes an average of 7 years to diagnose a rare disease. We are developing a comprehensive blood test for diagnosing rare diseases. These panels will be able to diagnose 100+ diseases to be used for newborn and parents screening.

Partner with Us

Therapeutics for Rare Diseases

It takes 10 to 15 years to develop treatments for rare diseases. We are building proprietary tools that will bring therapeutic solutions for multiple rare diseases, while decreasing the time to 3 – 5 years.

Speak with Us

Advancing Pediatric and Neonatal Care with Genomic Sequencing

We offer specialized genomic solutions to aid neonatologists, pediatricians, and gynecologists in providing the highest level of care, prioritizing the health of your youngest patients. Unlock the secrets of genomics with our cutting-edge sequencing services.
Experience our Services
AIIMS Delhi
AIIMS Delhi
DPU
DPU
PGIMER
PGIMER
ICGEB
ICGEB
ICMR
ICMR
DPSRU
DPSRU
SHROFFS
SHROFFS

We are collaborating with Industry leaders to solve rare diseases for newborns

Dr. Prabudh Goel
    Dr. Prabudh Goel

    Additional Professor, Paediatric Surgery AIIMS, New Delhi

    "Working with Vgenomics has been exceptional. Their precise whole exome sequencing, RNAseq, and bioinformatics analysis services, coupled with their knowledgeable scientific team ensured accurate analysis results. Vgenomics played a pivotal role in helping me uncover novel insights. I highly recommend them for top-notch genomics solutions."

    Dr. Mehak Vohra
      Dr. Mehak Vohra

      Research Scientist, SP-CORE

      "Vgenomics is my preferred choice for genomics services. Their team of experts displays a deep understanding of genomics and a commitment to quality that is unmatched. Highly recommended."

      Dr. Anil Tiwari
        Dr. Anil Tiwari

        Scientist D, Dr Shroff Charity Eye Hospital

        "Vgenomics has been an invaluable partner in my research journey. As a dedicated researcher, I rely on genomics services to fuel my projects. Vgenomics consistently delivers exceptional results. Collaborating with Vgenomics has not only expedited my research but has also enriched it. I wholeheartedly recommend Vgenomics for their outstanding genomics solutions."

        We are building a rare Biotech Company

        We are an international team working to revolutionize the way rare diseases are diagnosed and treated

        Join our Team

        Locations

        Quick Links

        Social

        Linkedin Instagram Youtube Facebook

        Copyright © 2023 Vgenomics | All rights reserved

        With a decade of diverse experience under his belt, Sameer Malik, an alumnus of the Delhi School of Economics, brings a robust blend of business strategy, finance, operations, and sales expertise to Vgenomics. From kick starting his career at KPMG to founding and scaling an e-commerce startup to over $1.5 million in annual revenues, and further contributing to the startup ecosystem through his involvement in Startup Nexus and Token Amigo, Sameer has navigated through various industries, consistently playing to his strategic and operational strengths. His rich entrepreneurial journey and strategic acumen are now channeled towards advancing Vgenomics' mission in the realm of rare inborn diseases diagnostics and therapeutic solutions.

        A translational biologist based in Silicon Valley, Dr. Lal brings her expertise in data science, translational medicine, clinical biomarker, and CDx implementation across all phases of clinical trials development to Vgenomics. With over 150 patents to her name, she has substantial experience in regulatory interactions with both the drug and device divisions of the FDA, and companion diagnostics (Dx) programs.

        After earning her doctorate from International Center of Genetic Engineering and Biotechnology (ICGEB), Dr. Sardar embarked on a mission to transform her research findings into practical applications that could benefit rare disease patients globally. She noticed a gap in dedicated solutions for the burgeoning hub of rare diseases in India, particularly those affecting children, and co-founded Vgenomics with Dr. Preeti to develop affordable diagnostics and therapeutic solutions.

        Open chat
        ✉ Hey! Need Help?
        Hello
        Can we help you?